---
document_datetime: 2024-10-22 14:19:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/otezla-epar-all-authorised-presentations_en.pdf
document_name: otezla-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8713175
conversion_datetime: 2025-12-23 06:02:16.164938
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/14/981/001   | Otezla   | 10 mg + 20 mg + 30 mg   | Film-coated tablet   | Oral use   | blister (PVC/alu) in a card   | Initiation pack: 27 tablets (4 x 10 mg + 4 x 20 mg + 19 x 30 mg)   |
|-------------------|----------|-------------------------|----------------------|------------|-------------------------------|--------------------------------------------------------------------|
| EU/1/14/981/002   | Otezla   | 30 mg                   | Film-coated tablet   | Oral use   | blister (PVC/alu)             | 56 tablets                                                         |
| EU/1/14/981/003   | Otezla   | 30 mg                   | Film-coated tablet   | Oral use   | blister (PVC/alu)             | 168 tablets                                                        |
| EU/1/14/981/004   | Otezla   | 10 mg + 20 mg           | Film-coated tablet   | Oral use   | blister (PVC/alu) in a card   | Initiation pack: 27 tablets (4 x 10 mg + 23 x 20 mg)               |
| EU/1/14/981/005   | Otezla   | 20 mg                   | Film-coated tablet   | Oral use   | blister (PVC/alu)             | 56 tablets                                                         |